Literature DB >> 18973923

Renal biopsy findings predicting outcome in scleroderma renal crisis.

Ibrahim Batal1, Robyn T Domsic, Aaron Shafer, Thomas A Medsger, Lawrence P Kiss, Parmjeet Randhawa, Sheldon Bastacky.   

Abstract

Scleroderma renal crisis is irreversible in some patients despite aggressive treatment. This study was designed to identify pathologic prognostic features in scleroderma renal crisis. We retrospectively reviewed the pathology and the clinical records of 17 patients who underwent kidney biopsies during scleroderma renal crisis (group A, recovered renal function [n = 7]; group B, remained in renal failure or died [n = 10]). Multiple histologic features were assessed semiquantitatively (0-3) or as percentages. C4d staining of peritubular capillaries and small vessels was assessed semiquantitatively (0-3) in patients with scleroderma (n = 11), normotensive (n = 10), and hypertensive (n = 12) nonscleroderma native kidney controls. The percentage of thrombosed vessels (25.1 +/- 21.0 versus 5.6 +/- 12.3, P = .045) and the severity of glomerular ischemic collapse (2.9 +/- 0.3 versus 1.4 +/- 0.8, P = .001) were significantly higher in group B than in group A. Also, group B patients tended to have more severe acute tubular injury and vascular fibrinoid changes. The peritubular capillary C4d score in patients with scleroderma, normotensive controls, and hypertensive controls were 1.1 +/- 0.9, 0.3 +/- 0.7, and 0.3 +/- 0.5, respectively (P = .018, scleroderma versus other controls). Small vessel C4d score was higher in scleroderma compared to normotensive but not hypertensive controls. Within scleroderma samples, a significantly higher peritubular capillary C4d score (1.6 +/- 0.7 versus 0.3 +/- 0.5, P = .024) but not small vessel score was found in group B compared to group A. This tended to be associated with peritubular capillary leukocyte margination. Vascular thrombosis, severe glomerular ischemic collapse, and peritubular capillary C4d deposits in scleroderma renal crisis kidney biopsies correlated with increased risk of failure to recover renal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973923     DOI: 10.1016/j.humpath.2008.08.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

1.  Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis.

Authors:  Ney Arencibia Pérez; María Luisa Agüera Morales; Rafael Sánchez Sánchez; Rosa María Ortega Salas; Rafael Ángel Fernández de la Puebla; Mario Espinosa Hernández
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

2.  Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibition.

Authors:  Muhammad Abdul Mabood Khalil; Nadia Iftikhar; Syed Ather Hussain; Jackson Tan
Journal:  CEN Case Rep       Date:  2012-09-28

3.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

Review 4.  Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.

Authors:  Cybele Ghossein; John Varga; Andrew Z Fenves
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

5.  Latest advances in connective tissue disorders.

Authors:  Vijay Rao; Simon Bowman
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

Review 6.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

7.  Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis.

Authors:  Jessica Salituri; Natalie Patey; Tomoko Takano; Pierre Fiset; Sonia Del Rincon; Laeora Berkson; Murray Baron; Marie Hudson
Journal:  J Scleroderma Relat Disord       Date:  2019-11-13

Review 8.  Diagnostic testing and interpretation of tests for autoimmunity.

Authors:  Christine Castro; Mark Gourley
Journal:  J Allergy Clin Immunol       Date:  2010-01-12       Impact factor: 10.793

Review 9.  Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

10.  Scleroderma renal crisis: a pathology perspective.

Authors:  Ibrahim Batal; Robyn T Domsic; Thomas A Medsger; Sheldon Bastacky
Journal:  Int J Rheumatol       Date:  2010-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.